Virus-like antigen display for cancer vaccine development, what is the potential?

Expert Rev Vaccines. 2018 Apr;17(4):285-288. doi: 10.1080/14760584.2018.1455505. Epub 2018 Mar 30.

Authors

Adam F Sander¹, Pier-Luigi Lollini²

Affiliations

¹ a Centre for Medical Parasitology at the Department of Immunology and Microbiology and Department of Infectious Diseases , University of Copenhagen, Copenhagen University Hospital , Copenhagen , Denmark.
² b Department of Experimental, Diagnostic and Specialty Medicine , University of Bologna , Bologna , Italy.

PMID: 29560746
DOI: 10.1080/14760584.2018.1455505

No abstract available

Keywords: HER-2; Virus-like particle; breast cancer; cancer vaccines; split-protein.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antigens, Viral / immunology
Cancer Vaccines / administration & dosage*
Cancer Vaccines / immunology
Drug Design
Humans
Neoplasms / immunology
Neoplasms / prevention & control*
Vaccines, Virus-Like Particle / administration & dosage*
Vaccines, Virus-Like Particle / immunology

Substances

Antigens, Viral
Cancer Vaccines
Vaccines, Virus-Like Particle